TLR4 and neoplasm: Taken together, our findings illustrate an innovative concept that a probiotic-derived siderophore can reprogram the pancreatic TME through TLR4, which is permissive to improve tumor immune surveillance and responsiveness to immune checkpoint inhibitors immunotherapies.